PLRZ
Polyrizon Ltd. NASDAQ Listed Oct 29, 2024$13.80
Mkt Cap $15.5M
52w Low $2.88
71.3% of range
52w High $18.20
50d MA $13.97
200d MA $11.10
P/E (TTM)
—
EV/EBITDA
—
P/B
1.1x
Debt/Equity
0.0x
ROE
-15.9%
P/FCF
-4.9x
RSI (14)
63.10
ATR (14)
$1.31
Beta
-4.55
50d MA
$13.97
200d MA
$11.10
Avg Volume
38.5K
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
5 Ha-Tidhar Street · Ra'anana 4366507 · IL
Data updated apr 26, 2026 7:58pm
· Source: financialmodelingprep.com